MultivisionDx

StratifAI

This company develops multimodal artificial intelligence biomarkers to predict cancer recurrence risks from pathology slides for oncologists and pharmaceutical organisations.

Waiv

This company develops artificial intelligence diagnostic tests and digital pathology software for oncology laboratories and healthcare providers to improve cancer patient treatment decisions.

Spotlight Medical

This company develops AI-driven prognosis tests to help oncologists select the most effective treatments for cancer patients.

KANVAS

This company develops spatial biology imaging technology and microbiome-based therapeutics for healthcare providers treating cancer and infectious diseases.

Imagenomix

The company develops an artificial intelligence platform that predicts cancer mutations from pathology images for healthcare providers and biopharma companies.

Persona-Dx

The company develops artificial intelligence biomarker tests for tissue and blood samples to help oncologists personalise cancer diagnosis and treatment for metastatic patients.

Digistain

This company develops a diagnostic test using infrared spectroscopy to provide breast cancer recurrence-risk stratification for oncologists and multidisciplinary clinical teams.

lunaphore

This company develops spatial biology platforms and automated tissue analysis systems for laboratories, hospitals and researchers to advance cancer diagnostics and drug development.